Our long-standing patent work in the chemical industry was the springboard from which we established Senniger Powers as one of the leading life sciences patent firms in the United States. Our firm has been involved in the life sciences area since its inception, working in areas from X-ray contrast media in the 1960s, to immunoassays in the 1970s, to a wide range of sophisticated technologies today.
Within our life sciences/pharmaceutical practice area, we have more than ten attorneys who hold degrees in biology, chemistry, chemical engineering or organic chemistry. Our clients’ work has focused on a range of technologies — from DNA polymerase and bioinformatics to recombinant plant products and animal pharmaceuticals.
Senniger Powers has consistently been ranked as one of the top biotechnology/drug patent firms in the nation.
Professionals in Life Sciences/Pharmaceutical Practice
- David E. Crawford, Jr.
- Sara Weilert Gillette
- Michael J. Hartley
- Janet S. Hendrickson, Ph.D.
- Benjamin J. Hodges
- Vincent M. Keil
- Elizabeth E. Millard, Ph.D.
- Kathleen M. Petrillo
- Eric J. Rakestraw
- John K. Roedel, Jr.
- Carrie Roskamp, Ph.D.
- John R. Schroeder
- Aleksandra Suri
- Mark A. Thomas
- Paul D. Tietz
- Marc W. Vander Tuig
- N. Chris Walters
- Andrew C. Wegman
How We Can Help You
Senniger Powers’ team of attorneys and technical experts provides sophisticated IP counsel to life sciences clients ranging from global pharmaceutical companies to promising start-ups. Kathleen Petrillo is the Group Leader of our Life Sciences/Pharmaceutical practice.